Search research articles
Contact Us
Filters
Showing results (1-10 of 269) with videos related to
Page
of 27
Sort By:
The New England Journal of Medicine
|
May 6, 1971
The morning-after pill
L M Demers
Clinics in Laboratory Medicine
|
December 1, 1984
Prostaglandins in human disease
L M Demers
Clinical Chemistry
|
February 1, 1993
A rapid, automated method for glycohemoglobin
L M Demers
Clinical Chemistry
|
July 1, 1979
Free thyroxine assay and thyroxine index compared
L M Demers
La Ricerca in Clinica E in Laboratorio
|
January 1, 1979
Serum bile acids (a new advance in the diagnosis of liver disease)
L M Demers
Breast Cancer Research and Treatment
|
January 1, 1994
Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients
L M Demers
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
January 1, 1997
Clinical usefulness of markers of bone degradation and formation
L M Demers
Clinical Chemistry
|
November 1, 1992
New biochemical marker for bone disease: is it a breakthrough?
L M Demers
Clinical Chemistry
|
March 1, 1991
Monoclonal antibodies to lutropin: are our immunoassays too specific?
L M Demers
Clinical Chemistry
|
August 3, 1999
Biochemical markers in the management of patients with metastatic bone disease
L M Demers
Page
of 27
Search research articles
Search
Showing results (1-10 of 269) with videos related to
Sort By:
Page
of 27
The New England Journal of Medicine
|
May 6, 1971
The morning-after pill
L M Demers
Clinics in Laboratory Medicine
|
December 1, 1984
Prostaglandins in human disease
L M Demers
Clinical Chemistry
|
February 1, 1993
A rapid, automated method for glycohemoglobin
L M Demers
Clinical Chemistry
|
July 1, 1979
Free thyroxine assay and thyroxine index compared
L M Demers
La Ricerca in Clinica E in Laboratorio
|
January 1, 1979
Serum bile acids (a new advance in the diagnosis of liver disease)
L M Demers
Breast Cancer Research and Treatment
|
January 1, 1994
Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients
L M Demers
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
January 1, 1997
Clinical usefulness of markers of bone degradation and formation
L M Demers
Clinical Chemistry
|
November 1, 1992
New biochemical marker for bone disease: is it a breakthrough?
L M Demers
Clinical Chemistry
|
March 1, 1991
Monoclonal antibodies to lutropin: are our immunoassays too specific?
L M Demers
Clinical Chemistry
|
August 3, 1999
Biochemical markers in the management of patients with metastatic bone disease
L M Demers
Page
of 27